Yozo Suzuoki

[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].

K Noda, Katie Tanaka, Makoto Ozaki, Kodai HIRABAYASI et autres

We conducted multi-site early phase II trial or oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer in cooperation with 19 institutes. Fifty mg/body of oral etoposide was administered daily for 21 consecutive days. Cycles were repeated …

jp (code pays fourni par la source)

Phase I study of NKT-01

Kazuo Tamura, Hisanobu Niitani, Masao Oguro, Ryuzo Ohno et autres

jp (code pays fourni par la source)

Phase I study of NKT-01

Kazuo Tamura, Hisanobu Niitani, Masao Oguro, Ryuzo Ohno et autres

jp (code pays fourni par la source)

Relation between the hormonal and epidemiological aspects of ovarian cancer patients in Japan.

Masahiko Kodama, Toshiko Kodama, R Totani, Yozo Suzuoki

We compared the hormonal and epidemiological aspects of ovarian cancer patients in search of the etiology of this neoplasia. Case-control studies of Japanese women with and without cancer were conducted in parallel, with regard to both the excretion of 14 urinary steroids …

[Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].

Masahiro Fukuoka, Tetsuji Miyazaki, Yasuhisa Yoshida, Masashi Hattori et autres

Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate), a derivative of cytosine arabinoside (Ara-C), was conducted by cooperative study groups between January 1986 and June 1987. The dosage for the single and 5-day oral administration ranged 50 to 1,200 and 100 to 900 mg/body/day, …

jp (code pays fourni par la source)

348 Progress of small GS with living embryo drawn from GS volume and CRL.

Sakae Goto, Ryozo Totani, Yozo Suzuoki, Tatsuo Kato

Proliferative Cell Index in Endometrial Adenocarcinoma of Different Nuclear Grades

Masafumi Mushika, Kanemitsu Shibata, Tadashi Miwa, Yozo Suzuoki et autres

Proliferative cell indices (PCI) in 20 cases of endometrial adenocarcinoma were obtained by staining DNA polymerase alpha. The PCI ranged from 11.1 to 42.1, averaging 24.7 +/- 8.7. Four cases of stage III all exhibited fairly large PCI (30.4-32.9). In contrast, in …

jp, us (code pays fourni par la source)

[Phase I study and early phase II of SM-108 (4-carbamoylimidazolium-5-olate) in lung cancer. SM-108 Study Group].

Kiyoji Kimura, Yozo Suzuoki, M Ogawa, Toru Miyazaki et autres

Phase I study with a new oral purine antagonist, SM-108, was conducted in a total of 73 cases in a 5-day consecutive schedule with the dosage ranging from 20-2,500 mg/m2 at II institutes. The incidences of subjective and objective side effects were …

jp (code pays fourni par la source)

363. Detection of Proliferative Cells in Trophoblastic Epithelium of Term Placenta

N. Mushika, Tetsuya Yamada, Nobuyoshi KUROKI, T Miwa et autres

359. The Index Around 10 Weeks of Gestation for Poor Outcome of Pregnancy in Cases of Vaginal Bleeding and/or Echo-free Space in Ultrasonography

Saori Goto, Norihiro Kuroki, R Totani, Yozo Suzuoki et autres

518. Frequency of Positiveness for ATLV-antibody among Pregnant Women in Toukai Area and Positive Rate of IgA-antibody in their Milk

T. Katahira, Teppei Yamada, Masafumi Mushika, Nao Kuroki et autres

Detection of proliferative cells in dysplasia, carcinoma in situ, and invasive carcinoma of the uterine cervix by monoclonal antibody against DNA polymerase α

Masafumi Mushika, Tadashi Miwa, Yozo Suzuoki, Kazuma Hayashi et autres

The distribution of DNA polymerase alpha-positive cells in neoplasia of the uterine cervix and in normal cervical epithelium was studied using a monoclonal antibody against DNA polymerase alpha. The positive cells were found only in the parabasal layer of normal cervical epithelium …

jp (code pays fourni par la source)